Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls
Antipsychotics (APs) are the cornerstone of treatment for schizophrenia (SCZ) but are unfortunately associated with serious metabolic adverse effects including weight gain and type 2 diabetes. The pathophysiology of AP-induced metabolic dysfunction is largely undetermined. Brain insulin resistance h...
Main Authors: | Nicolette Stogios, Laurie Hamel, Emily Smith, Marcos Sanches, Gary Remington, Aristotle Voineskos, Satya Dash, Ariel Graff-Guerrero, Margaret Hahn, Sri Mahavir Agarwal |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704670/?tool=EBI |
Similar Items
-
Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls.
by: Nicolette Stogios, et al.
Published: (2022-01-01) -
Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis.
by: Sally Wu, et al.
Published: (2023-01-01) -
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review
by: Raghunath Singh, et al.
Published: (2022-05-01) -
Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis
by: Pruntha Kanagasundaram, et al.
Published: (2021-03-01) -
Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
by: Nicole E. MacKenzie, et al.
Published: (2018-12-01)